Literature DB >> 23013131

Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-α in human proximal tubular cells.

Kento Kitada1, Daisuke Nakano, Hirofumi Hitomi, Hiroyuki Kobori, Kazushi Deguchi, Hirohito Mori, Tsutomu Masaki, Akira Nishiyama.   

Abstract

1. Aldosterone has been shown to mediate p21-dependent cellular senescence in rat kidney proximal tubules in vivo and in cultured human proximal tubular cells. The p21-induced senescent cells express higher levels of apoptotic cytokines, such as tumour necrosis factor (TNF)-α compared with non-senescent cells. The aim of the present study was to investigate the hypothesis that aldosterone increases proximal tubular apoptosis by increasing the secretion of apoptosis-inducing factors through a p21-dependent mechanism. 2. Human proximal tubular cells were incubated with aldosterone (10 nmol/L) and cell senescence was detected by senescence-associated β-galactosidase staining and expression of p21. Apoptosis was analysed by terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labelling and annexin/propidium iodide staining, whereas p21 localization was determined by immunofluorescence. 3. Exposure of cells to aldosterone for 3 or 5 days increased senescence-associated β-galactosidase staining, p21 and TNF-α mRNA expression and secretion of TNF-α into the culture medium. These changes were abolished by gene silencing of p21. Aldosterone failed to increase the number of apoptotic cells on day 3, but did increase them on day 5. A neutralizing antibody against TNF-α prevented the aldosterone-induced apoptotic changes. Aldosterone did not affect localization of p21. 4. These findings indicate that aldosterone increases TNF-α synthesis and secretion in proximal tubular cells via p21/senescence-dependent cell phenotypic changes and that the TNF-α secreted plays an important role as a paracrine factor in mediating cell apoptosis, indicating a possible involvement in aldosterone-induced renal damage.
© 2012 The Authors Clinical and Experimental Pharmacology and Physiology © 2012 Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013131      PMCID: PMC3478382          DOI: 10.1111/1440-1681.12001

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  38 in total

1.  Organ aging and susceptibility to cancer may be related to the geometry of the stem cell niche.

Authors:  Krastan B Blagoev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.

Authors:  Yu-Yan Fan; Ryoko Baba; Yukiko Nagai; Akira Miyatake; Naohisa Hosomi; Shoji Kimura; Guang-Ping Sun; Masakazu Kohno; Mamoru Fujita; Youichi Abe; Akira Nishiyama
Journal:  Hypertens Res       Date:  2006-03       Impact factor: 3.872

3.  Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

Authors:  Shinji Kume; Takashi Uzu; Kihachiro Horiike; Masami Chin-Kanasaki; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

4.  SGLT2 mediates glucose reabsorption in the early proximal tubule.

Authors:  Volker Vallon; Kenneth A Platt; Robyn Cunard; Jana Schroth; Jean Whaley; Scott C Thomson; Hermann Koepsell; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

5.  Aldosterone/Mineralocorticoid receptor stimulation induces cellular senescence in the kidney.

Authors:  Yu-Yan Fan; Masakazu Kohno; Hirofumi Hitomi; Kento Kitada; Yoshihide Fujisawa; Junichi Yatabe; Midori Yatabe; Robin A Felder; Hiroyuki Ohsaki; Kazi Rafiq; Shamshad J Sherajee; Takahisa Noma; Akira Nishiyama; Daisuke Nakano
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

6.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.

Authors:  Darren J Baker; Tobias Wijshake; Tamar Tchkonia; Nathan K LeBrasseur; Bennett G Childs; Bart van de Sluis; James L Kirkland; Jan M van Deursen
Journal:  Nature       Date:  2011-11-02       Impact factor: 49.962

7.  EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.

Authors:  Meng Wang; Fabian Morsbach; David Sander; Liliana Gheorghiu; Akash Nanda; Cyril Benes; Malte Kriegs; Mechthild Krause; Ekkehard Dikomey; Michael Baumann; Jochen Dahm-Daphi; Jeffrey Settleman; Henning Willers
Journal:  Cancer Res       Date:  2011-08-18       Impact factor: 12.701

8.  Differential roles for Chk1 and FANCD2 in ATR-mediated signalling for psoralen photoactivation-induced senescence.

Authors:  Miriam G Hovest; Thomas Krieg; Gernot Herrmann
Journal:  Exp Dermatol       Date:  2011-11       Impact factor: 3.960

9.  Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.

Authors:  C A Carvajal; A A Herrada; C R Castillo; F J Contreras; C B Stehr; L M Mosso; A M Kalergis; C E Fardella
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

10.  Cellular senescence limits regenerative capacity and allograft survival.

Authors:  Heidi Braun; Bernhard M W Schmidt; Mirja Raiss; Arpita Baisantry; Dan Mircea-Constantin; Shijun Wang; Marie-Luise Gross; Manuel Serrano; Roland Schmitt; Anette Melk
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

View more
  6 in total

1.  Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.

Authors:  Tatsuyori Morita; Daisuke Nakano; Kento Kitada; Satoshi Morimoto; Atsuhiro Ichihara; Hirofumi Hitomi; Hiroyuki Kobori; Ichiro Shiojima; Akira Nishiyama
Journal:  Eur J Pharmacol       Date:  2015-03-26       Impact factor: 4.432

2.  Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.

Authors:  Kento Kitada; Daisuke Nakano; Hiroyuki Ohsaki; Hirofumi Hitomi; Tohru Minamino; Junichi Yatabe; Robin A Felder; Hirohito Mori; Tsutomu Masaki; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Diabetes Complications       Date:  2014-06-04       Impact factor: 2.852

3.  Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.

Authors:  Keisuke Ohnishi; Miki Murase; Daisuke Nakano; Nicolas Pelisch; Hirofumi Hitomi; Hiroyuki Kobori; Satoshi Morimoto; Hirohito Mori; Tsutomu Masaki; Koji Ohmori; Masakazu Kohno; Atsuhiro Ichihara; Akira Nishiyama
Journal:  J Pharmacol Sci       Date:  2013-05-22       Impact factor: 3.337

4.  Dual inhibiting senescence and epithelial-to-mesenchymal transition by erythropoietin preserve tubular epithelial cell regeneration and ameliorate renal fibrosis in unilateral ureteral obstruction.

Authors:  Adis Tasanarong; Supranee Kongkham; Sookkasem Khositseth
Journal:  Biomed Res Int       Date:  2013-11-19       Impact factor: 3.411

5.  Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition.

Authors:  Yukiko Kato; Kiyoshi Mori; Masato Kasahara; Keisuke Osaki; Akira Ishii; Keita P Mori; Naohiro Toda; Shoko Ohno; Takashige Kuwabara; Takeshi Tokudome; Ichiro Kishimoto; Moin A Saleem; Taiji Matsusaka; Kazuwa Nakao; Masashi Mukoyama; Motoko Yanagita; Hideki Yokoi
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

6.  Cellular Senescence in Human Aldosterone-Producing Adrenocortical Cells and Related Disorders.

Authors:  Jacopo Pieroni; Yuto Yamazaki; Xin Gao; Yuta Tezuka; Hiroko Ogata; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Yasuhiro Nakamura; Fumitoshi Satoh; Hironobu Sasano
Journal:  Biomedicines       Date:  2021-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.